Adolescent Hepatitis C: Prevalence, Impact, and Management Challenges

References

• Setiawan VW, Stram DO, Porcel J, Lu SC, Le Marchand L, Noureddin M. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology. 2016;64(6):1969–1977. doi:10.1002/hep.28677
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Viral hepatitis surveillance – United States; 2018. https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm. July 2020. Accessed Dec 13, 2020.
   Google Scholar
• Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000;90(10):1562–1569. doi:10.2105/ajph.90.10.1562
   PubMed Web of Science ®Google Scholar
• Shah N, Pierce T, Kowdley KV. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C. Expert Opin Investig Drugs. 2013;22(9):1107–1121. doi:10.1517/13543784.2013.806482
   PubMed Web of Science ®Google Scholar
• Squires JE, Balistreri WF. Hepatitis C virus infection in children and adolescents. Hepatol Commun. 2017;1(2):87–98. doi:10.1002/hep4.1028
   PubMed Web of Science ®Google Scholar
• Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453–458.
   PubMed Web of Science ®Google Scholar
• Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis C virus infection in children and adolescents [published correction appears in Lancet Gastroenterol Hepatol. 2020 May;5(5):e4]. Lancet Gastroenterol Hepatol. 2019;4(6):477–487. doi:10.1016/S2468-1253(19)30046-9
   PubMed Web of Science ®Google Scholar
• Espinosa C, Jhaveri R, Barritt AS. Unique challenges of hepatitis c in infants, children, and adolescents. Clin Ther. 2018;40(8):1299–1307. doi:10.1016/j.clinthera.2018.07.010
   Web of Science ®Google Scholar
• Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59(10):1411–1419. doi:10.1093/cid/ciu643
   PubMed Web of Science ®Google Scholar
• Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016. Hepatology. 2019;69(3):1020–1031. doi:10.1002/hep.30297
   PubMed Web of Science ®Google Scholar
• Schmelzer J, Dugan E, Blach S, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020;5(4):374–392. doi:10.1016/S2468-1253(19)30385-1
   PubMed Web of Science ®Google Scholar
• El-Sayed M, Razavi H. P1263: global estimate of HCV infection in the pediatric and adolescent population. J Hepatol. 2015;62:S831–S832. doi:10.1016/s0168-8278(15)31458-6
   Web of Science ®Google Scholar
• Beech BM, Myers L, Beech DJ. Hepatitis B and C infections among homeless adolescents. Fam Community Health. 2002;25(2):28–36. doi:10.1097/00003727-200207000-00005
   PubMed Web of Science ®Google Scholar
• Fernandes ND, Banik S, Abughali N, Sthapit B, Abdullah N, Fragassi P. Hepatitis C virus screening among adolescents attending a drug rehabilitation center. J Pediatric Infect Dis Soc. 2020;9(4):437–441. doi:10.1093/jpids/piz065
   PubMed Web of Science ®Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341(8):556–562. doi:10.1056/NEJM199908193410802
   PubMed Web of Science ®Google Scholar
• Delgado-Borrego A, Smith L, Jonas MM, et al. Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys. J Pediatr. 2012;161(5):915–921. doi:10.1016/j.jpeds.2012.05.002
   Web of Science ®Google Scholar
• Leung DH, Squires JE, Jhaveri R, et al. Hepatitis C in 2020: a north American society for pediatric gastroenterology, hepatology, and nutrition position paper. J Pediatr Gastroenterol Nutr. 2020;71(3):407–417. doi:10.1097/MPG.0000000000002814
   Web of Science ®Google Scholar
• Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77–87. doi:10.1002/hep.27259
   PubMed Web of Science ®Google Scholar
• Blach S, Zeuzem S, Manns M; Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–176. doi:10.1016/S2468-1253(16)30181-9
   PubMed Web of Science ®Google Scholar
• Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis c screening among adults - United States, 2020. MMWR Recomm Rep. 2020;69(2):1–17. doi:10.15585/mmwr.rr6902a1
   Web of Science ®Google Scholar
• Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014;59(6):765–773. doi:10.1093/cid/ciu447
   PubMed Web of Science ®Google Scholar
• Schillie SF, Canary L, Koneru A, et al. Hepatitis C virus in women of childbearing age, pregnant women, and children. Am J Prev Med. 2018;55(5):633–641. doi:10.1016/j.amepre.2018.05.029
   PubMed Web of Science ®Google Scholar
• Global Hepatitis Report 2017. Geneva: World Health Organization; 2017.
   Google Scholar
• Bortolotti F, Verucchi G, Cammà C, et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology. 2008;134(7):1900–1907. doi:10.1053/j.gastro.2008.02.082
   PubMed Web of Science ®Google Scholar
• Casiraghi MA, De Paschale M, Romanò L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology. 2004;39(1):90–96. doi:10.1002/hep.20030
   Web of Science ®Google Scholar
• Mohan P, Barton BA, Narkewicz MR, et al. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study. Hepatology. 2013;58(5):1580–1586. doi:10.1002/hep.26519
   Web of Science ®Google Scholar
• Nydegger A, Srivastava A, Wake M, Smith AL, Hardikar W. Health-related quality of life in children with hepatitis C acquired in the first year of life. J Gastroenterol Hepatol. 2008;23(2):226–230. doi:10.1111/j.1440-1746.2007.04859.x
   PubMed Web of Science ®Google Scholar
• Rodrigue JR, Balistreri W, Haber B, et al. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr. 2009;48(3):341–347. doi:10.1097/MPG.0b013e318185998f
   PubMed Web of Science ®Google Scholar
• Northrop JM. A dirty little secret: stigma, shame and hepatitis C in the health setting. Med Humanit. 2017;43(4):218–224. doi:10.1136/medhum-2016-011099
   PubMed Web of Science ®Google Scholar
• Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–658. doi:10.1016/j.jpeds.2005.12.051
   PubMed Web of Science ®Google Scholar
• Khaderi S, Shepherd R, Goss JA, Leung DH. Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol. 2014;20(32):11281–11286. doi:10.3748/wjg.v20.i32.11281
   Web of Science ®Google Scholar
• Mizuochi T, Takano T, Yanagi T, et al. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan. J Gastroenterol. 2018;53(3):419–426. doi:10.1007/s00535-017-1351-0
   Web of Science ®Google Scholar
• European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis. 2005;41(1):45–51. doi:10.1086/430601.
   PubMed Web of Science ®Google Scholar
• Modin L, Arshad A, Wilkes B, et al. Epidemiology and natural history of hepatitis C virus infection among children and young people. J Hepatol. 2019;70(3):371–378. doi:10.1016/j.jhep.2018.11.013
   PubMed Web of Science ®Google Scholar
• Turkova A, Volynets GV, Crichton S, et al. Advanced liver disease in Russian children and adolescents with chronic hepatitis C. J Viral Hepat. 2019;26(7):881–892. doi:10.1111/jvh.13093
   Web of Science ®Google Scholar
• Indolfi G, Bartolini E, Serranti D, Azzari C, Resti M. Hepatitis C in children co-infected with human immunodeficiency virus. J Pediatr Gastroenterol Nutr. 2015;61(4):393–399. doi:10.1097/MPG.0000000000000895
   PubMed Web of Science ®Google Scholar
• Novo-Veleiro I, Alvela-Suárez L, Chamorro AJ, González-Sarmiento R, Laso FJ, Marcos M. Alcoholic liver disease and hepatitis C virus infection. World J Gastroenterol. 2016;22(4):1411–1420. doi:10.3748/wjg.v22.i4.1411
   Web of Science ®Google Scholar
• Goossens N, Negro F. The impact of obesity and metabolic syndrome on chronic hepatitis C. Clin Liver Dis. 2014;18(1):147–156. doi:10.1016/j.cld.2013.09.007
   Web of Science ®Google Scholar
• Epstein RL, Wang J, Hagan L, et al. Hepatitis C virus antibody testing among 13- to 21-Year-olds in a large sample of US federally qualified health centers. JAMA. 2019;322(22):2245–2248. doi:10.1001/jama.2019.16196
   Web of Science ®Google Scholar
• Malik F, Bailey H, Chan P, et al. Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines. JHEP Rep. 2021;3(2):100227. doi:10.1016/j.jhepr.2021.100227
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013;62(18):362–365.
   PubMed Web of Science ®Google Scholar
• Chevaliez S. Strategies for the improvement of HCV testing and diagnosis. Expert Rev Anti Infect Ther. 2019;17(5):341–347. doi:10.1080/14787210.2019.1604221
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Hepatitis C. In: Kimberlin DW, Brady MT, Jackson MA, Long SS editors, Red Book: 2018 Report of the Committee on Infectious Diseases. 31st. Itasca, IL: American Academy of Pediatrics; 2018:430–431.
   Google Scholar
• Easterbrook PJ; WHO Guidelines Development Group. WHO to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries. J Hepatol. 2016;65(1 Suppl):S46–S66. doi:10.1016/j.jhep.2016.08.002
   PubMed Web of Science ®Google Scholar
• Tang W, Chen W, Amini A, et al. Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature. BMC Infect Dis. 2017;17(Suppl S1):695. doi:10.1186/s12879-017-2773-2
   Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address: [email protected]. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017;66(1):153–194. doi:10.1016/j.jhep.2016.09.
   PubMed Web of Science ®Google Scholar
• Balistreri WF, Murray KF, Rosenthal P, et al. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12–17 years old with hepatitis C virus genotype 1 infection. Hepatology. 2017;66(2):371–378. doi:10.1002/hep.28995
   PubMed Web of Science ®Google Scholar
• Chung RT, Ghany MG, Kim AY; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2018 Update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. 2018;67(10):1477–1492. doi:10.1093/cid/ciy585
   PubMed Web of Science ®Google Scholar
• Indolfi G, Hierro L, Dezsofi A, et al. Treatment of chronic hepatitis c virus infection in children: a position paper by the hepatology committee of European Society of paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):505–515. doi:10.1097/MPG.0000000000001872
   PubMed Web of Science ®Google Scholar
• Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Martin NK, Vickerman P, Dore GJ, et al. Prioritization of HCV treatment in the direct-acting antiviral era: an economic evaluation. J Hepatol. 2016;65(1):17–25. doi:10.1016/j.jhep.2016.02.007
   PubMed Web of Science ®Google Scholar
• Nguyen J, Barritt AS, Jhaveri R. Cost effectiveness of early treatment with direct-acting antiviral therapy in adolescent patients with hepatitis C virus infection. J Pediatr. 2019;207:90–96. doi:10.1016/j.jpeds.2018.12.012
   Web of Science ®Google Scholar
• Aspinall EJ, Corson S, Doyle JS, et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis. 2013;57(Suppl 2):S80–S89. doi:10.1093/cid/cit306
   PubMed Web of Science ®Google Scholar
• Bregenzer A, Conen A, Knuchel J, et al. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Swiss Med Wkly. 2017;147:w14544. doi:10.4414/smw.2017.14544
   PubMed Web of Science ®Google Scholar
• Schlabe S, Rockstroh JK. Advances in the treatment of HIV/HCV coinfection in adults. Expert Opin Pharmacother. 2018;19(1):49–64. doi:10.1080/14656566.2017.1419185
   PubMed Web of Science ®Google Scholar
• Freriksen JJM, van Seyen M, Judd A, et al. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment Pharmacol Ther. 2019;50(7):738–750. doi:10.1111/apt.15476
   PubMed Web of Science ®Google Scholar
• Nwaohiri A, Schillie S, Bulterys M, Kourtis AP. Towards elimination of hepatitis C virus infection in children. Lancet Child Adolesc Health. 2018;2(4):235–237. doi:10.1016/S2352-4642(18)30069-5
   Google Scholar
• Chappell CA, Scarsi KK, Kirby BJ, et al. Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study. Lancet Microbe. 2020;1(5):e200–e208. doi:10.1016/S2666-5247(20)30062-8
   PubMedGoogle Scholar
• El-Shabrawi MH, Kamal NM. Burden of pediatric hepatitis C. World J Gastroenterol. 2013;19(44):7880–7888. doi:10.3748/wjg.v19.i44.7880
   PubMed Web of Science ®Google Scholar
• WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar